Boston Scientific Betting $1.5 Billion: Market Bets and Implications
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Risk parity assigns capital to balance risk contributions across asset classes in retirement portfolios, aiming for steadier, more resilient returns.
26,821 articlesA bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
A notable institutional purchase in Plains GP Holdings hints at a larger, value-driven view of the energy midstream s...
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
SpaceX going public $1.8 trillion would be the biggest IPO in history. This guide explains what that means for everyd...
Osasuna is under fire after reports it used a Kalshi contract to hedge the financial hit of relegation. The club deni...
Contrarian investors are eyeing simply good foods stock as a potential turnaround play. This article breaks down the ...
When Intuitive Machines announced a major equity raise, the stock sold off hard. But a disciplined look shows the mov...
Adobe has faced a significant stock drop, but a lower price isn’t the same as a bargain. This guide breaks down what ...
SpaceX headlines grab attention, but smart investors look for durable earnings growth in established aerospace player...
Palantir’s business is booming, yet its stock has struggled. This article breaks down why growth and stock moves aren...
On days when upbeat earnings flood the headlines, the Nasdaq sometimes slips instead of rallying. This article explai...
As 2026 unfolds, investors face a choice between StubHub's fast-growing digital ticketing platform and Build-A-Bear's...